Area of research
Oncology · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Thyroid Cancer Diagnosis and Treatment, and Thyroid Disorders and Treatments.
Medullary Thyroid Carcinoma and Clinical Outcomes in Heterozygous Carriers of the <i>RET</i> K666N Germline Pathogenic Variant
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024
A pathologically expanded, clonal lineage of IL-21–producing CD4+ T cells drives inflammatory neuropathy
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium
Clonally expanded, thyrotoxic effector CD8 <sup>+</sup> T cells driven by IL-21 contribute to checkpoint inhibitor thyroiditis
Prognostic Value of Preoperative Molecular Testing and Implications for Initial Surgical Management in Thyroid Nodules Harboring Suspected (Bethesda V) or Known (Bethesda VI) Papillary Thyroid Cancer
Spectrum of Clinical Presentations, Imaging Findings, and HLA Types in Immune Checkpoint Inhibitor–Induced Hypophysitis
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology
Inhibition of IL-17A Protects against Thyroid Immune-Related Adverse Events while Preserving Checkpoint Inhibitor Antitumor Efficacy
Pathogenic TNF-α drives peripheral nerve inflammation in an Aire-deficient model of autoimmunity
Anaplastic Large Cell Lymphoma Occurring in Women with Breast Implants
Immunogenicity of Murine Solid Tumor Models as a Defining Feature of In Vivo Behavior and Response to Immunotherapy